Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. GlobalData uses proprietary data and analytics to provide a comprehensive report on the arteriotomy closure devices market in France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the arteriotomy closure devices market in France was Abbott Laboratories followed by Advanced Vascular Dynamics, Cordis, Haemonetics, LeMaitre Vascular, Marine Polymer Technologies, Medtronic, Merit Medical Systems, Teleflex and Terumo.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression. Passive closure devices and Active closure devices are tracked under this segment. Arteriotomy closure devices tracked here are used only in coronary interventions and peripheral vascular interventions. Active closure devices are used for the percutaneous closure of artery access sites in patients who have undergone diagnostic endovascular catheterization procedures. Passive closure devices provide controlled compression of the percutaneous access arteries without completely occluding vessel flow.
The arteriotomy closure devices market in France can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size arteriotomy closure devices in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
